Fortive Corporation

FTV

NYSE

53.75

USD

+0.37(+0.69%)

As of today

Overview Financials Dividends Ratios Discussions Analysis

Fortive Corporation fundamentals

Overview Income Statement Balance Sheet Cash Flow

Key ratios

P/E Ratio

21.16

Price/Book

2.73

Debt/Equity

50.84%

Return on Equity

6.46%

Dividend Yield

0.45%

EBITDA

1.67B

Fortive Corporation designs, develops, manufactures, markets, and services professional and engineered products, software, and services worldwide. Its Intelligent Operating Solutions segment offers connected reliability tools; environment, health, safety, and quality enterprise software products; facility and asset lifecycle software; pre-construction planning and construction procurement solutions; ruggedized professional test tools; electric, pressure, and temperature calibration tools; and portable gas detection tools for a range of vertical end markets including manufacturing, process industries, healthcare, utilities and power, communications and electronics, and others. It markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, PRUFTECHNIK, and SERVICECHANNEL brands. The company's Precision Technologies segment provides electrical test and measurement instruments and services; energetic material devices; and sensor and control system solutions for power and energy, medical equipment, food and beverage, aerospace and defense, off-highway vehicles, electronics, semiconductors, and other general industrial markets. This segment markets its products under the ANDERSON-NEGELE, GEMS, SETRA, HENGSTLER-DYNAPAR, QUALITROL, PACIFIC SCIENTIFIC, KEITHLEY, and TEKTRONIX brands. Its Advanced Healthcare Solutions segment offers hardware and software products and services, including instrument and device reprocessing, instrument tracking, biomedical test tools, radiation safety monitoring, and asset management services; subscription-based surgical inventory management systems to facilitate inventory management and regulatory compliance, as well as technical, analytical, and compliance services to determine radiation exposure services under the ASP, CENSIS, CENSITRAC, EVOTECH, FLUKE BIOMEDICAL, INVETECH, LANDAUER, RAYSAFE, and STERRAD brands. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.

Statements Highlights

AnnualQuarterly

Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Total Revenue	4,634,400,000	5,254,700,000	5,825,700,000	6,065,300,000	6,231,800,000
Gross Profit	2,616,700,000	3,009,900,000	3,363,400,000	3,594,100,000	3,731,000,000
Operating Income	650,200,000	831,500,000	1,005,300,000	1,133,700,000	1,176,700,000
Net Income	1,613,300,000	608,400,000	755,200,000	865,800,000	832,900,000
Total Assets	16,051,500,000	16,465,500,000	15,890,600,000	16,911,800,000	17,016,100,000
Total Current Liabilities	2,860,800,000	3,714,900,000	2,727,100,000	1,791,300,000	2,238,400,000
Total Equity	8,972,700,000	9,517,000,000	9,688,600,000	10,325,300,000	10,195,600,000
Free Cash Flow	1,361,000,000	911,100,000	1,207,400,000	1,245,800,000	1,406,400,000
Cash from Operations	1,436,700,000	961,100,000	1,303,200,000	1,353,600,000	1,526,800,000
Cash from Investing	-148,400,000	-2,615,600,000	-102,500,000	-195,400,000	-1,796,000,000
Cash from Financing	-696,100,000	652,000,000	-1,273,000,000	32,300,000	-792,700,000
Net Change in Cash	619,600,000	-1,005,500,000	-110,100,000	1,179,600,000	-1,075,500,000

Fortive Corporation

FTV

53.75

Fortive Corporation fundamentals

Key ratios

Statements Highlights

Dividends

Analyst Recomendations